Your session is about to expire
← Back to Search
Marijuana + Opioids for Opioid Use Disorder
Study Summary
This trial will study the effects of marijuana and opioids, alone and in combination, on abuse-related measures and physiological outcomes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a healthy adult between 18 and 50 years old.You are currently using opioids or marijuana for purposes other than medical treatment.I am a healthy adult between 18 and 50 years old.I am a healthy adult between 18 and 50 years old.You are currently using opioids or marijuana for non-medical reasons.
- Group 1: Opioid Agonist/Marijuana Combination
- Group 2: Vaporized Marijuana
- Group 3: Opioid Agonist
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the total number of participants involved in this clinical trial?
"Affirmative. Per the details on clinicaltrials.gov, this medical study is actively seeking participants. It was originally posted to the site in June 2019 and its most recent update was made October 2021; 105 patients are being recruited from a single location."
Are there any potential risks associated with Opioid Agonist treatment?
"This medication has been subject to limited clinical research, so it was given a rating of 1 for safety. This Phase 1 trial is still in the early stages and only provides partial data on efficacy and overall protection."
Are there any openings in this clinical research study at the moment?
"As current records on clinicaltrials.gov demonstrate, this trial is actively seeking participants to enrol in their study. It was first announced June 21st 2019 and the latest update was posted October 21 2022."
Could you please provide an overview of other research conducted involving Opioid Agonist?
"At present, 31 clinical trials related to Opioid Agonists are in progress with 3 of those studies at Phase 3. Notably, there are 46 total sites running these experiments; many located within Hartford, Connecticut."
Might I be eligible to partake in this clinical trial?
"For this research initiative, 105 adults aged between 18 and 50 with existing marijuana use are necessary. Applicants must fulfill the following prerequisites: Adults in good health age 18-50, Current non-clinical consumption of opioids and cannabis."
Is this investigation a pioneering endeavor?
"At present, there are 31 studies for opioid agonist being conducted in 32 cities and 5 countries. The inaugural trial, sponsored by Jazz Pharmaceuticals, was initiated in 2015 and saw 200 patients through Phase 2 & 3 clinical trials. Since then, a further 60 investigations have been carried out."
Does this research offer an opportunity to those above the age of fifty?
"This trial's criteria states that patients must be between 18 to 50 years old. Additionally, there are 32 studies for minors and 179 trials for seniors over 65."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger